Baby boy was treated with the first personalized gene-editing drug | MIT Technology Review

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely rare genetic diseases.

This baby boy was treated with the first personalized gene-editing drug | MIT Technology Review Skip to Content Doctors say they constructed a bespoke gene-editing treatment in less than seven months and used it to treat a baby with a deadly metabolic condition. The rapid-fire attempt to rewrite the child’s DNA marks the first time gene editing has been tailored to treat a single individual, according to a report published in the New England Journal of Medicine . The baby who was treated, Kyle “KJ” Muldoon Jr., suffers from a rare metabolic condition caused by a particularly unusual gene missp

related reading

• The Practical Guide to Superbabies — LessWronglesswrong.com
• Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living Humansforbes.com
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Futurencbi.nlm.nih.gov
• George Church: The Future Without Limit | Innovators | National Geographicnationalgeographic.com
• Harvard researchers share views on future, ethics of gene editing — Harvard Gazettenews.harvard.edu
• FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
• Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
• Curative gene therapies for rare diseases - PMCncbi.nlm.nih.gov
• Rebuild Biotech for the AI Era | Benchlingbenchling.com
• Medicine's Endgamenotboring.co
• Designer Babies: A Dystopian Sidetrack Of Gene Editingmedicalfuturist.com
• Announcing Preventive — Preventivepreventive.bio